Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras

"TETRALONAS 5-SUBSTITUìDAS COMO INIBIDORES DE FARNESIL TRANSFERASE DE RAS". A presente invenção provê tetralonas 5-substituídas das Fórmulas (I), (II), (III) e (IV) e seus sais, ésteres, amidas e pró-drogas farmaceuticamente aceitáveis, que são úteis para o tratamento e prevenção de prolif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DANIELE MARIE LEONARD, DOUGLAS S. JOHNSON, JAMES STANLEY KAL TENBRONN, RICHARD H. HUTCHINGS, GORDON WILLIAM REWCASTLE, HO HUAT LEE, JOSEPH THOMAS REPINE, WILLIAM ALEXANDER DENNY, JARED BRUCE JOHN MILBANK, ANDREW DAVID WHITE
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DANIELE MARIE LEONARD
DOUGLAS S. JOHNSON
JAMES STANLEY KAL TENBRONN
RICHARD H. HUTCHINGS
GORDON WILLIAM REWCASTLE
HO HUAT LEE
JOSEPH THOMAS REPINE
WILLIAM ALEXANDER DENNY
JARED BRUCE JOHN MILBANK
ANDREW DAVID WHITE
description "TETRALONAS 5-SUBSTITUìDAS COMO INIBIDORES DE FARNESIL TRANSFERASE DE RAS". A presente invenção provê tetralonas 5-substituídas das Fórmulas (I), (II), (III) e (IV) e seus sais, ésteres, amidas e pró-drogas farmaceuticamente aceitáveis, que são úteis para o tratamento e prevenção de proliferação de tecidos incontrolada ou anormal, tal como câncer, aterosclerose, restenose e psoríase. Especificamente, a presente invenção refere-se a compostos que inibem a enzima farnesil transferase. The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR0110142A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR0110142A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR0110142A3</originalsourceid><addsrcrecordid>eNrjZPAMSS0pSszJz0ssVjDVLS5NKi7JLCk9vCYFyE_Oz81XyMzLTMpMyS9KLVZISVVISyzKSy3OzFEAasorTkstSixOBYkDaR4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu8UZGBoaGBoYuRoTFgFAIWzNI0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras</title><source>esp@cenet</source><creator>DANIELE MARIE LEONARD ; DOUGLAS S. JOHNSON ; JAMES STANLEY KAL TENBRONN ; RICHARD H. HUTCHINGS ; GORDON WILLIAM REWCASTLE ; HO HUAT LEE ; JOSEPH THOMAS REPINE ; WILLIAM ALEXANDER DENNY ; JARED BRUCE JOHN MILBANK ; ANDREW DAVID WHITE</creator><creatorcontrib>DANIELE MARIE LEONARD ; DOUGLAS S. JOHNSON ; JAMES STANLEY KAL TENBRONN ; RICHARD H. HUTCHINGS ; GORDON WILLIAM REWCASTLE ; HO HUAT LEE ; JOSEPH THOMAS REPINE ; WILLIAM ALEXANDER DENNY ; JARED BRUCE JOHN MILBANK ; ANDREW DAVID WHITE</creatorcontrib><description>"TETRALONAS 5-SUBSTITUìDAS COMO INIBIDORES DE FARNESIL TRANSFERASE DE RAS". A presente invenção provê tetralonas 5-substituídas das Fórmulas (I), (II), (III) e (IV) e seus sais, ésteres, amidas e pró-drogas farmaceuticamente aceitáveis, que são úteis para o tratamento e prevenção de proliferação de tecidos incontrolada ou anormal, tal como câncer, aterosclerose, restenose e psoríase. Especificamente, a presente invenção refere-se a compostos que inibem a enzima farnesil transferase. The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme</description><edition>7</edition><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030121&amp;DB=EPODOC&amp;CC=BR&amp;NR=0110142A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030121&amp;DB=EPODOC&amp;CC=BR&amp;NR=0110142A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DANIELE MARIE LEONARD</creatorcontrib><creatorcontrib>DOUGLAS S. JOHNSON</creatorcontrib><creatorcontrib>JAMES STANLEY KAL TENBRONN</creatorcontrib><creatorcontrib>RICHARD H. HUTCHINGS</creatorcontrib><creatorcontrib>GORDON WILLIAM REWCASTLE</creatorcontrib><creatorcontrib>HO HUAT LEE</creatorcontrib><creatorcontrib>JOSEPH THOMAS REPINE</creatorcontrib><creatorcontrib>WILLIAM ALEXANDER DENNY</creatorcontrib><creatorcontrib>JARED BRUCE JOHN MILBANK</creatorcontrib><creatorcontrib>ANDREW DAVID WHITE</creatorcontrib><title>Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras</title><description>"TETRALONAS 5-SUBSTITUìDAS COMO INIBIDORES DE FARNESIL TRANSFERASE DE RAS". A presente invenção provê tetralonas 5-substituídas das Fórmulas (I), (II), (III) e (IV) e seus sais, ésteres, amidas e pró-drogas farmaceuticamente aceitáveis, que são úteis para o tratamento e prevenção de proliferação de tecidos incontrolada ou anormal, tal como câncer, aterosclerose, restenose e psoríase. Especificamente, a presente invenção refere-se a compostos que inibem a enzima farnesil transferase. The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAMSS0pSszJz0ssVjDVLS5NKi7JLCk9vCYFyE_Oz81XyMzLTMpMyS9KLVZISVVISyzKSy3OzFEAasorTkstSixOBYkDaR4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu8UZGBoaGBoYuRoTFgFAIWzNI0</recordid><startdate>20030121</startdate><enddate>20030121</enddate><creator>DANIELE MARIE LEONARD</creator><creator>DOUGLAS S. JOHNSON</creator><creator>JAMES STANLEY KAL TENBRONN</creator><creator>RICHARD H. HUTCHINGS</creator><creator>GORDON WILLIAM REWCASTLE</creator><creator>HO HUAT LEE</creator><creator>JOSEPH THOMAS REPINE</creator><creator>WILLIAM ALEXANDER DENNY</creator><creator>JARED BRUCE JOHN MILBANK</creator><creator>ANDREW DAVID WHITE</creator><scope>EVB</scope></search><sort><creationdate>20030121</creationdate><title>Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras</title><author>DANIELE MARIE LEONARD ; DOUGLAS S. JOHNSON ; JAMES STANLEY KAL TENBRONN ; RICHARD H. HUTCHINGS ; GORDON WILLIAM REWCASTLE ; HO HUAT LEE ; JOSEPH THOMAS REPINE ; WILLIAM ALEXANDER DENNY ; JARED BRUCE JOHN MILBANK ; ANDREW DAVID WHITE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR0110142A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DANIELE MARIE LEONARD</creatorcontrib><creatorcontrib>DOUGLAS S. JOHNSON</creatorcontrib><creatorcontrib>JAMES STANLEY KAL TENBRONN</creatorcontrib><creatorcontrib>RICHARD H. HUTCHINGS</creatorcontrib><creatorcontrib>GORDON WILLIAM REWCASTLE</creatorcontrib><creatorcontrib>HO HUAT LEE</creatorcontrib><creatorcontrib>JOSEPH THOMAS REPINE</creatorcontrib><creatorcontrib>WILLIAM ALEXANDER DENNY</creatorcontrib><creatorcontrib>JARED BRUCE JOHN MILBANK</creatorcontrib><creatorcontrib>ANDREW DAVID WHITE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DANIELE MARIE LEONARD</au><au>DOUGLAS S. JOHNSON</au><au>JAMES STANLEY KAL TENBRONN</au><au>RICHARD H. HUTCHINGS</au><au>GORDON WILLIAM REWCASTLE</au><au>HO HUAT LEE</au><au>JOSEPH THOMAS REPINE</au><au>WILLIAM ALEXANDER DENNY</au><au>JARED BRUCE JOHN MILBANK</au><au>ANDREW DAVID WHITE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras</title><date>2003-01-21</date><risdate>2003</risdate><abstract>"TETRALONAS 5-SUBSTITUìDAS COMO INIBIDORES DE FARNESIL TRANSFERASE DE RAS". A presente invenção provê tetralonas 5-substituídas das Fórmulas (I), (II), (III) e (IV) e seus sais, ésteres, amidas e pró-drogas farmaceuticamente aceitáveis, que são úteis para o tratamento e prevenção de proliferação de tecidos incontrolada ou anormal, tal como câncer, aterosclerose, restenose e psoríase. Especificamente, a presente invenção refere-se a compostos que inibem a enzima farnesil transferase. The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR0110142A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Tetralonas 5-substituìdas como inibidores de farnesil transferase de ras
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A42%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DANIELE%20MARIE%20LEONARD&rft.date=2003-01-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR0110142A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true